Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
131 studies found for:    "Sjogren's Syndrome"
Show Display Options
Rank Status Study
21 Unknown  Sex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on Fatigue
Condition: Sjogren's Syndrome
Intervention: Drug: dehydroepiandrosterone
22 Recruiting Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome
Condition: Sjogren's Syndrome
Interventions: Drug: Belimumab;   Drug: Rituximab;   Drug: Placebo belimumab;   Drug: Placebo rituximab
23 Completed Anti-CD20 Antibody Therapy for Sjogren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Drug: Rituximab
24 Not yet recruiting Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity
Condition: Primary Sjögren's Syndrome
Intervention: Other: Blood samples
25 Recruiting A Study of LY3090106 in Participants With Sjögren's Syndrome (SS)
Condition: Sjögren's Syndrome
Interventions: Drug: LY3090106;   Drug: Placebo
26 Recruiting A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's Syndrome
Condition: Sjogren's Syndrome
Interventions: Drug: Matching Placebo;   Drug: RO5459072
27 Not yet recruiting Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome
Condition: Sjogren's Syndrome
Interventions: Drug: Filgotinib;   Drug: GS-9876;   Drug: Tirabrutinib;   Drug: Filgotinib placebo;   Drug: GS-9876 placebo;   Drug: Tirabrutinib placebo
28 Withdrawn Study of Pharmacodynamic Effects of VAY736 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: VAY736 lower dose;   Drug: VAY736 higher dose
29 Completed Hydroxychloroquine Versus Placebo in Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: Hydroxychloroquine;   Drug: Placebo
30 Recruiting Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome
Condition: Sjögren's Syndrome
Interventions: Drug: BMS-931699;   Drug: BMS-986142;   Drug: Placebo
31 Not yet recruiting Inflammatory Myopathies in Primary Sjögren's Syndrome
Condition: Primary Sjögren Syndrome
Intervention:
32 Unknown  Confocal Microscopy and Lacrimal Gland in Sjogren's Syndrome
Condition: Primary Sjogren's Syndrome
Intervention:
33 Not yet recruiting Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)
Condition: Primary Sjogren's Syndrome
Interventions: Biological: VAY736;   Other: Placebo
34 Recruiting A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: hrIL-2 active;   Drug: hrIL-2 placebo
35 Terminated
Has Results
Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, for Treatment of Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Biological: Baminercept;   Other: Placebo
36 Recruiting A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Biological: AMG 557/MEDI5872;   Other: Placebo
37 Recruiting Safety, Pharmacokinetics, and Preliminary Efficacy Study of CDZ173 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: CDZ173;   Drug: Placebo
38 Recruiting Is Sjögren's Syndrome Associated With Meibomian Gland Dysfunction ?
Conditions: Sjögren's Syndrome;   Meibomian Gland Dysfunction
Interventions: Drug: Tears Naturale Forte;   Drug: liposic
39 Unknown  Efficacy of Tocilizumab in Primary Sjögren's Syndrome.
Condition: Primary Sjögren's Syndrome (pSS)
Interventions: Drug: Tocilizumab;   Drug: Placebo
40 Unknown  Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS)
Conditions: Sjogren's Syndrome;   Mesenchymal Stem Cells
Intervention: Biological: Allogeneic Mesenchymal Stem Cells (AlloMSC)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.